Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-12-27
2005-12-27
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S404000, C546S275400, C548S372500
Reexamination Certificate
active
06979693
ABSTRACT:
The present invention relates to certain pyrazole derivatives of Formula (I):that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
REFERENCES:
patent: 5256634 (1993-10-01), Schallnor et al.
patent: 5712303 (1998-01-01), Faraci et al.
patent: 6376527 (2002-04-01), Goldstein et al.
patent: 19518054 (1996-09-01), None
patent: 0 129 846 (1985-01-01), None
patent: 2100973 (1972-03-01), None
patent: 4731979 (1972-11-01), None
patent: WO-94/13643 (1994-06-01), None
patent: WO 96/10568 (1996-04-01), None
Tupper, et al.,Synthesis, vol. 3: pp 337-341 (1997) “Steric and electronic control in the addition of hydrazine and phenylhydrazine to α-[(dimethylamino)methylene]-β-oxoarylpropanenitriles”.
Rudorf, et al.,J. Prakt. Chem., vol. 320:4, pp 585-599 (1978) “Acylketen-S,S-und Acylketen-S,N-acetale als Bausteine fur Heterocyclen: Pyrazole und Isoxazole”.
Butler, et al.,J. Med. Chem., vol. 27: pp 1396-1400 (1984) “(1,3-Dialkyl-5-amino-1H-pyrazol-4-yl)arylmethanones. A Series of Novel Central Nervous System Depressants”.
Nishiwaki, et al.,J. Chem. Soc., Perkin Trans I., vol. 15, pp 1871-1875 (1974) “Studies on Heterocyclic Chemistry. Part XIX. Synthesis of 4-Aroyl-1-arylpyrazoles from α -Aroyl-β-anilinoacrylonitriles and Photochemistry of 4-Carbonyl-substituted Pyrazoles”.
Goldstein David Michael
Labadie Sharada Shenvi
Rotstein David Mark
Sjogren Eric Brian
Talamas Francisco Xavier
Hall Robert C.
Stockton Laura L.
Syntex (U.S.A.) LLC
LandOfFree
Pyrazole derivatives-p38 MAP kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazole derivatives-p38 MAP kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole derivatives-p38 MAP kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3476379